1 |
Xu, Y., Zhao, F., Wang, Z., Song, Y., Luo, Y., Zhang, X., Jiang, L., Sun, Z., Miao, Z. and Xu, H. (2012) MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1. Oncogene 31, 1398-1407.
DOI
|
2 |
Liu, M., Lang, N., Qiu, M., Xu, F., Li, Q., Tang, Q., Chen, J., Chen, X., Zhang, S., Liu, Z., Zhou, J., Zhu, Y., Deng, Y., Zheng, Y. and Bi, F. (2011) miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells. Int. J. Cancer. 128, 1269-1279.
DOI
ScienceOn
|
3 |
Asangani, I. A., Rasheed, S. A., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S. and Allgayer, H. (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27, 2128-2136.
DOI
ScienceOn
|
4 |
Weber, D. G., Johnen, G., Bryk, O., Jockel, K. H. and Bruning, T. (2012) Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma--a pilot study. PLoS One 7, e30221.
DOI
|
5 |
Niquet, J. and Wasterlain, C. G. (2004) Bim, Bad, and Bax: a deadly combination in epileptic seizures. J. Clin. Invest. 113, 960-962.
DOI
ScienceOn
|
6 |
Danial, N. N. and Korsmeyer, S. J. (2004) Cell death: critical control points. Cell 116, 205-219.
DOI
ScienceOn
|
7 |
Shapiro, G. I. (2006) Cyclin-dependent kinase pathways as targets for cancer treatment. J. Clin. Oncol. 24, 1770-1783.
DOI
ScienceOn
|
8 |
Xu, Y. (2008) Induction of genetic instability by gain-offunction p53 cancer mutants. Oncogene 27, 3501-3507.
DOI
ScienceOn
|
9 |
Vousden, K. H. and Lane, D. P. (2007) p53 in health and disease. Nat. Rev. Mol. Cell Biol. 8, 275-283.
DOI
ScienceOn
|
10 |
Calin, G. A. and Croce, C. M. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857-866
DOI
ScienceOn
|
11 |
Yu, D., Zhou, H., Xun, Q., Xu, X., Ling, J. and Hu, Y. (2012) microRNA-103 regulates the growth and invasion of endometrial cancer cells through the downregulation of tissue inhibitor of metalloproteinase 3. Oncol. Lett. 3, 1221-1226.
DOI
|
12 |
Annibali, D., Gioia, U., Savino, M., Laneve, P., Caffarelli, E. and Nasi, S. (2012) A new module in neural differentiation control: two microRNAs upregulated by retinoic acid, miR-9 and -103, target the differentiation inhibitor ID2. PLoS One 7, e40269.
DOI
|
13 |
Sato, F., Wu, Y., Bhawal, U. K., Liu, Y., Imaizumi, T., Morohashi, S., Kato, Y. and Kijima, H. (2011) PERIOD1 (PER1) has anti-apoptotic effects, and PER3 has pro-apoptotic effects during cisplatin (CDDP) treatment in human gingival cancer CA9-22 cells. Eur. J. Cancer 47, 1747-1758.
DOI
ScienceOn
|
14 |
Chen, H. Y., Lin, Y. M., Chung, H. C., Lang, Y. D., Lin, C. J., Huang, J., Wang, W. C., Lin, F. M., Chen, Z., Huang, H. D., Shyy, J. Y., Liang, J. T. and Chen, R. H. (2012) miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res. 72, 3631-3641.
DOI
ScienceOn
|
15 |
Sahar, S. and Sassone-Corsi, P. (2009) Metabolism and cancer: the circadian clock connection. Nat. Rev. Cancer 9, 886-896.
DOI
ScienceOn
|
16 |
Zhu, Y., Stevens, R. G., Hoffman, A. E., Fitzgerald, L. M., Kwon, E. M., Ostrander, E. A., Davis, S., Zheng, T. and Stanford, J. L. (2009) Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study. Cancer Res. 69, 9315-9322.
DOI
ScienceOn
|
17 |
Mazzoccoli, G., Panza, A., Valvano, M. R., Palumbo, O., Carella, M., Pazienza, V., Biscaglia, G., Tavano, F., Di Sebastiano, P., Andriulli, A. and Piepoli, A. (2011) Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients. Chronobiol. Int. 28, 841-851.
DOI
ScienceOn
|
18 |
Matsuo, T., Yamaguchi, S., Mitsui, S., Emi, A., Shimoda, F. and Okamura, H. (2003) Control mechanism of the circadian clock for timing of cell division in vivo. Science 302, 255-259.
DOI
ScienceOn
|
19 |
Gery, S. and Koeffler, H. P. (2007) The role of circadian regulation in cancer. Cold. Spring. Harb. Symp. Quant. Biol. 72, 459-464.
DOI
ScienceOn
|
20 |
Buhr, E. D. and Takahashi, J. S. (2013) Molecular components of the Mammalian circadian clock. Handb. Exp. Pharmacol. 217, 3-27.
DOI
|
21 |
Wang, X., Yan, D., Teng, M., Fan, J., Zhou, C., Li, D., Qiu, G., Sun, X., Li, T., Xing, T., Tang, H., Peng, X. and Peng, Z. (2012) Reduced expression of PER3 is associated with incidence and development of colon cancer. Ann. Surg. Oncol. 19, 3081-3088.
DOI
ScienceOn
|
22 |
Gaziel-Sovran, A., Segura, M. F., Di Micco, R., Collins, M. K., Hanniford, D., Vega-Saenz, D. M. E., Rakus, J. F., Dankert, J. F., Shang, S., Kerbel, R. S., Bhardwaj, N., Shao, Y., Darvishian, F., Zavadil, J., Erlebacher, A., Mahal, L. K., Osman, I. and Hernando, E. (2011) miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell. 20, 104-118.
DOI
ScienceOn
|